The purchase of innovative equipment for functional diagnostics and the continued non-intrusive monitoring of the disease process for chronic respiratory diseases in particular in infants and young children (Q94871): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The aim and main aim of the project is to enable the non-invasive diagnosis of respiratory conditions in infants and young children and on persons whose diagnostics cannot be made for different reasons. The segments included in the diagnostic equipment should be able to analyse the following parameters: — Respiratory, — FRC (functional breathing volume) and non-ventilation ventilation, — LCI (lung clearenadex) and SnIII analysis — measurement...) |
(Created claim: summary (P836): The aim and main objective of the project is to enable non-invasive diagnosis of respiratory dysfunction in infants and young children and in people who have different types of diagnostics for different reasons. The segments included in the diagnostic equipment shall be able to analyse the following parameters: — respiratory volume, – FRC (active respiratory volume) and non-homogenicity of ventilation, – LCI (lung clearenace index) and SNIII ana...) |
||||||||||||||
| Property / summary | |||||||||||||||
The aim and main objective of the project is to enable non-invasive diagnosis of respiratory dysfunction in infants and young children and in people who have different types of diagnostics for different reasons. The segments included in the diagnostic equipment shall be able to analyse the following parameters: — respiratory volume, – FRC (active respiratory volume) and non-homogenicity of ventilation, – LCI (lung clearenace index) and SNIII analysis, – measurement of FRC using nitrogen leaching method, – optional measurement of FeNO, capnography, oxymetries and measurement of respiratory resistance using occlusion method. The project is intended for medical staff – doctors, electroradiology technicians, who will perform the examination in the main target group, i.e. infants, young children and people whose other type of diagnosis is impossible for various reasons. The project results in early detection of respiratory dysfunction in the above-mentioned patients (whose detection is not possible using other non-invasive methods) and monitoring of the disease process and possible modification of treatment of rare diseases, including cystic fibrosis. The effect is to improve the quality of diagnosis, treatment and monitoring of chronic respiratory diseases. The use of this method is used in the assessment of the respiratory function of prematurely born newborns. These objectives can only be achieved by purchasing the equipment that is the subject of the project. The purchase is planned for the first quarter of 2016. As a result of the realisation of the investment will increase the competitive position of the Company, attractiveness of the offer, and joining the leading diagnostic centres in the world. (English) | |||||||||||||||
| Property / summary: The aim and main objective of the project is to enable non-invasive diagnosis of respiratory dysfunction in infants and young children and in people who have different types of diagnostics for different reasons. The segments included in the diagnostic equipment shall be able to analyse the following parameters: — respiratory volume, – FRC (active respiratory volume) and non-homogenicity of ventilation, – LCI (lung clearenace index) and SNIII analysis, – measurement of FRC using nitrogen leaching method, – optional measurement of FeNO, capnography, oxymetries and measurement of respiratory resistance using occlusion method. The project is intended for medical staff – doctors, electroradiology technicians, who will perform the examination in the main target group, i.e. infants, young children and people whose other type of diagnosis is impossible for various reasons. The project results in early detection of respiratory dysfunction in the above-mentioned patients (whose detection is not possible using other non-invasive methods) and monitoring of the disease process and possible modification of treatment of rare diseases, including cystic fibrosis. The effect is to improve the quality of diagnosis, treatment and monitoring of chronic respiratory diseases. The use of this method is used in the assessment of the respiratory function of prematurely born newborns. These objectives can only be achieved by purchasing the equipment that is the subject of the project. The purchase is planned for the first quarter of 2016. As a result of the realisation of the investment will increase the competitive position of the Company, attractiveness of the offer, and joining the leading diagnostic centres in the world. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The aim and main objective of the project is to enable non-invasive diagnosis of respiratory dysfunction in infants and young children and in people who have different types of diagnostics for different reasons. The segments included in the diagnostic equipment shall be able to analyse the following parameters: — respiratory volume, – FRC (active respiratory volume) and non-homogenicity of ventilation, – LCI (lung clearenace index) and SNIII analysis, – measurement of FRC using nitrogen leaching method, – optional measurement of FeNO, capnography, oxymetries and measurement of respiratory resistance using occlusion method. The project is intended for medical staff – doctors, electroradiology technicians, who will perform the examination in the main target group, i.e. infants, young children and people whose other type of diagnosis is impossible for various reasons. The project results in early detection of respiratory dysfunction in the above-mentioned patients (whose detection is not possible using other non-invasive methods) and monitoring of the disease process and possible modification of treatment of rare diseases, including cystic fibrosis. The effect is to improve the quality of diagnosis, treatment and monitoring of chronic respiratory diseases. The use of this method is used in the assessment of the respiratory function of prematurely born newborns. These objectives can only be achieved by purchasing the equipment that is the subject of the project. The purchase is planned for the first quarter of 2016. As a result of the realisation of the investment will increase the competitive position of the Company, attractiveness of the offer, and joining the leading diagnostic centres in the world. (English) / qualifier | |||||||||||||||
point in time: 15 October 2020
| |||||||||||||||
Revision as of 17:33, 15 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The purchase of innovative equipment for functional diagnostics and the continued non-intrusive monitoring of the disease process for chronic respiratory diseases in particular in infants and young children |
Project in Poland financed by DG Regio |
Statements
105,000.0 zloty
0 references
300,000.0 zloty
0 references
35.0 percent
0 references
10 December 2015
0 references
15 February 2016
0 references
CENTRUM MEDYCZNE KARPACZ SPÓŁKA AKCYJNA
0 references
50°45'50.4"N, 15°44'42.7"E
0 references
Przedmiotem i głównym celem projektu jest umożliwienie bezinwazyjnej diagnostyki zaburzeń czynnościowych układu oddechowego u niemowląt i małych dzieci oraz u osób, u których innego typu diagnostyka z różnych przyczyn jest niemożliwa. Wchodzące w skład sprzętu diagnostycznego segmenty powinny mieć możliwość analizy następujących parametrów: - objętości oddechowej, - FRC (czynnościowej objętości oddechowej) i niehomogenności wentylacji, - LCI (lung clearenace index) i analizy SnIII, - pomiar FRC przy zastosowaniu metody wypłukiwania azotu, - opcjonalnie pomiar FeNO, kapnografię, oxymetrie i pomiar oporu dróg oddechowych metodą okluzji.Zakres rzeczowy projektu obejmuje zakup, dostawę, instalację sprzętu oraz przeszkolenie personelu. Projekt przeznaczony jest dla kadry medycznej - lekarze, technicy elektroradiologii, którzy będą wykonywać badanie u głównej grupy docelowej, a więc niemowląt, małych dzieci oraz osób, u których innego typu diagnostyka jest niemożliwa z różnych przyczyn. Efektem projektu jest wczesne wykrycie zaburzeń czynnościowych układu oddechowego w/w pacjentów, (których wykrycie nie jest możliwe przy użyciu innych bezinwazyjnych metod) oraz monitorowanie procesu chorobowego i ewentualna modyfikacja leczenia m.in. chorób rzadkich, w tym szczególnie mukowiscydozy. Efektem jest poprawa jakości diagnostyki, leczenia i monitorowania przewlekłych chorób układu oddechowego. Wykorzystanie tej metody znajduje zastosowanie w ocenie czynności układu oddechowego przedwcześnie urodzonych noworodków. Wskazane cele będą mogły zostać osiągnięte jedynie poprzez zakup sprzętu będącego przedmiotem projektu. Realizacja zakupu planowana jest na I kwartał 2016 roku. W efekcie realizacji inwestycji zwiększy się pozycja konkurencyjna Spółki, atrakcyjność oferty, oraz dołączenie do wiodących ośrodków diagnostycznych na świecie. (Polish)
0 references
The aim and main objective of the project is to enable non-invasive diagnosis of respiratory dysfunction in infants and young children and in people who have different types of diagnostics for different reasons. The segments included in the diagnostic equipment shall be able to analyse the following parameters: — respiratory volume, – FRC (active respiratory volume) and non-homogenicity of ventilation, – LCI (lung clearenace index) and SNIII analysis, – measurement of FRC using nitrogen leaching method, – optional measurement of FeNO, capnography, oxymetries and measurement of respiratory resistance using occlusion method. The project is intended for medical staff – doctors, electroradiology technicians, who will perform the examination in the main target group, i.e. infants, young children and people whose other type of diagnosis is impossible for various reasons. The project results in early detection of respiratory dysfunction in the above-mentioned patients (whose detection is not possible using other non-invasive methods) and monitoring of the disease process and possible modification of treatment of rare diseases, including cystic fibrosis. The effect is to improve the quality of diagnosis, treatment and monitoring of chronic respiratory diseases. The use of this method is used in the assessment of the respiratory function of prematurely born newborns. These objectives can only be achieved by purchasing the equipment that is the subject of the project. The purchase is planned for the first quarter of 2016. As a result of the realisation of the investment will increase the competitive position of the Company, attractiveness of the offer, and joining the leading diagnostic centres in the world. (English)
15 October 2020
0 references
Identifiers
RPDS.01.05.01-02-0033/15
0 references